← Leaderboards
Danielle C Ompad
New York Academy Of Medicine
$7,149,819
Attributed
$9,094,066
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,876,785 · 7
By mechanism
R01$6,387,372 · 3
U19$1,782,719 · 1
P30$1,735,969 · 1
R56$583,635 · 1
R21$387,090 · 1
Top collaborators
- Perry N Halkitis4 shared
- Farzana Kapadia4 shared
Most similar at New York Academy Of Medicine
Same institution · by research overlap
- David H Vlahov$30,228,718
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelDrug UsageSamplingEpidemiologyCommunitiesCharacteristicsTrainingParticipantBaseAffectAids PreventionLiteratureHiv InfectionsInterviewInfectionMonitorNeighborhoodsEvaluationEnvironmentEconomicsIncidenceAwarenessDisadvantagedAids/Hiv Problem
Grant awards (20)
Center for the Study of Complex Malaria in India$1,782,719
U19 · FY2023 · AI · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$348,603
P30 · FY2022 · DA · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$348,591
P30 · FY2021 · DA · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$324,299
P30 · FY2020 · DA · contact PI
Application of a syndemic framework to HPV and HSV infection in emergent adult men$768,654
R01 · FY2019 · AI · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$348,777
P30 · FY2019 · DA · contact PI
Application of a syndemic framework to HPV and HSV infection in emergent adult men$776,149
R01 · FY2018 · AI · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$365,699
P30 · FY2018 · DA · contact PI
Application of a syndemic framework to HPV and HSV infection in emergent adult men$787,932
R01 · FY2017 · AI · contact PI
Application of a syndemic framework to HPV and HSV infection in emergent adult men$583,635
R56 · FY2015 · AI · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$419,931
R01 · FY2011 · DA · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$178,888
R01 · FY2011 · DA · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$635,590
R01 · FY2010 · DA · contact PI
Methods for Evaluating the Physical and Social Environment of Urban Neighborhoods$175,950
R21 · FY2009 · DA · contact PI
Club Drug Use and HIV Risks among Minorities in NYC$681,596
R01 · FY2008 · DA · contact PI
Methods for Evaluating the Physical and Social Environment of Urban Neighborhoods$211,140
R21 · FY2008 · DA · contact PI
Club Drug Use and HIV Risks among Minorities in NYC$696,017
R01 · FY2007 · DA · contact PI
Club Drug Use and HIV Risks among Minorities in NYC$714,127
R01 · FY2006 · DA · contact PI
Club Drug Use and HIV Risks among Minorities in NYC$7,000
R01 · FY2006 · DA · contact PI
Club Drug Use and HIV Risks among Minorities in NYC$721,488
R01 · FY2005 · DA